Overview
Vonoprazan-Based Triple Therapy in Comparison With Extended Sequential Therapy
Status:
Recruiting
Recruiting
Trial end date:
2025-02-28
2025-02-28
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study aims to compare the efficacy of the current standard first-line anti-helicobacter pylori regimen, extended proton pump inhibitor-based sequential therapy, with that of vonoprazan-based triple therapy, through a randomized controlled trial.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Fu Jen Catholic University Hospital
Criteria
Inclusion Criteria:- Patients with H.pylori infection who was over 20 years old and agree to participate in
the trial will be recruited.
Exclusion Criteria:
- Who had received helicobacter pylori eradication before
- Who are known to be allergic to any drug used in this trial
- Pregnant women
- Who are refuse to participate in the trial for any reason